Primary cutaneous anaplastic large-cell lymphoma successfully treated with intralesional brentuximab vedotin: a case report

被引：2
|
作者：
Arroyo-Andres, Jorge [1 ]
Agud-Dios, Manuel [1 ]
Rubio-Muniz, Carmen A. [1 ]
Vico-Alonso, Cristina [1 ]
Cortijo-Cascajares, Susana [2 ]
Ortiz-Romero, Pablo L. [1 ]
机构：
[1] Univ Complutense, 12 Octubre Hosp, Sch Med, CIBERONC,Dept Dermatol,Inst I 12, Madrid, Spain
[2] 12 Octubre Univ Hosp, Pharm Dept, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2022年 / 61卷 / 07期
关键词：
PAPULOSIS;
D O I：
10.1111/ijd.15834
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E267 / E269
页数：3
相关论文
共 50 条
  • [41] Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma
    Ishizawa, Kenichi
    Yanai, Tomoko
    ADVANCES IN THERAPY, 2019, 36 (10) : 2679 - 2696
  • [42] Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma
    Kenichi Ishizawa
    Tomoko Yanai
    Advances in Therapy, 2019, 36 : 2679 - 2696
  • [43] Intralesional brentuximab vedotin for the treatment of primary cutaneous T-cell lymphomas: a case series
    Arroyo-Andres, Jorge
    Agud-Dios, Manuel
    Rubio-Muniz, Carmen A.
    Postigo, Concepcion
    Cortijo-Cascajares, Susana
    Ortiz-Romero, Pablo L.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (02) : e57 - e59
  • [44] FingolimodPrimary cutaneous CD30+ anaplastic large-cell lymphoma: case report
    Reactions Weekly, 2019, 1737 (1) : 136 - 136
  • [45] Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large-cell lymphoma treated with brentuximab vedotin: A case series
    Contarini, Giorgia
    Carraro, Elisa
    Lovisa, Federica
    Martire, Gaia
    Lo Nigro, Luca
    Sala, Alessandra
    Pillon, Marta
    Mussolin, Lara
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (01) : 352 - 355
  • [46] Complete Response of Relapsed Systemic and Cutaneous Anaplastic Large Cell Lymphoma Using Brentuximab Vedotin: 2 Case Reports
    Broccoli, Alessandro
    Derenzini, Enrico
    Pellegrini, Cinzia
    Narducci, Riccardo
    Stefani, Giulia
    Casadei, Beatrice
    Argnani, Lisa
    Zinzani, Pier Luigi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 493 - 495
  • [47] Dramatic progression of multifocal primary cutaneous anaplastic large-cell lymphoma
    Avallone, Gianluca
    Leo, Francesco
    Astrua, Chiara
    Mastorino, Luca
    Parente, Renato
    Grassi, Marcella
    Fabrizio, Renato
    Ferraris, Andrea
    Quaglino, Pietro
    Ribero, Simone
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2024, 159 (02) : 215 - 216
  • [48] KI-1 ANAPLASTIC PRIMARY CUTANEOUS LARGE-CELL LYMPHOMA
    STENIER, C
    BOURLOND, A
    HUMBLET, Y
    DERMATOLOGY, 1995, 190 (04) : 332 - 334
  • [49] Detection of Chlamydophila pneumoniae and human herpesvirus 8 in primary cutaneous anaplastic large-cell lymphoma: a case report
    Alessandro Borghi
    Elisabetta Caselli
    Dario Di Luca
    Adolfo Sebastiani
    Paolo Perri
    Silva Seraceni
    Carlo Contini
    Annarosa Virgili
    Infectious Agents and Cancer, 8
  • [50] PRIMARY CUTANEOUS ANAPLASTIC LARGE-CELL LYMPHOMA WITH A PROLONGED ERYTHRODERMIC PRODROME
    DENTON, K
    WILSON, CL
    VENNING, VA
    BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (03) : 297 - 300
12345